REQUEST A DEMO
Total
USD $0.00
Search more companies

Anadolu Pharma Ecza Deposu Ltd. Sti. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Anadolu Pharma Ecza Deposu Limited Sirketi Profile Updated: December 12, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Anadolu Pharma Ecza Deposu Ltd. Sti. is based in Turkiye, with the head office in Konya. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The company was established on October 22, 2018. It currently has a total number of 69 (2022) employees. There was a net sales revenue increase of 23.09% reported in Anadolu Pharma Ecza Deposu Ltd. Sti.’s latest financial highlights for 2021. Its total assets grew by 84.78% over the same period. In 2021, Anadolu Pharma Ecza Deposu Ltd. Sti.’s net profit margin increased by 0.62%.

Headquarters
No:39-1 Fevzicakmak Mahallesi Hudai Caddesi Karatay
Konya; Central Anatolia; Postal Code: 42050

Contact Details: Purchase the Anadolu Pharma Ecza Deposu Ltd. Sti. report to view the information.

Website: http://www.anadoluecza.com

Basic Information
Total Employees:
Purchase the Anadolu Pharma Ecza Deposu Ltd. Sti. report to view the information.
Outstanding Shares:
Purchase the Anadolu Pharma Ecza Deposu Ltd. Sti. report to view the information.
Incorporation Date:
October 22, 2018
Key Executives
Purchase this report to view the information.
Company Manager
Company Performance
Financial values in the chart are available after Anadolu Pharma Ecza Deposu Ltd. Sti. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
23.09%
Total operating revenue
23.09%
Operating profit (EBIT)
94.51%
Net Profit (Loss) for the Period
79.84%
Total assets
84.78%
Total equity
282.38%
Operating Profit Margin (ROS)
0.94%
Net Profit Margin
0.62%
Return on Equity (ROE)
-11.57%
Quick Ratio
0.1%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?